[
  {
    "ts": "2026-02-03T00:00:00+00:00",
    "headline": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
      "content": {
        "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
        "contentType": "VIDEO",
        "title": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
        "description": "<p>Market Domination Overtime Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Chipotle Mexican Grill (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/CMG\">CMG</a>), Pfizer (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>), and Merck (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/MRK\">MRK</a>), and the Senate hearing on Netflix's (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/NFLX\">NFLX</a>) proposed bid to acquire Warner Bros. Discovery (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/WBD\">WBD</a>).</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2026-02-03T00:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UzqQCDUXj0MPW_tlpZ7E0A--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n0CeAGm.cJ44Rdq8zCs3Mw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T03:14:36+00:00",
    "headline": "Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration",
    "summary": "Amgen (AMGN) has just walked away from its licensing and collaboration agreement with Kyowa Kirin on rocatinlimab for atopic dermatitis, a portfolio reshuffle that shifts responsibility back to Kyowa Kirin and repositions Amgen’s near term pipeline focus. See our latest analysis for Amgen. Those portfolio moves sit alongside a share price that has climbed to US$344.68, with a 30 day share price return of 5.2% and a 1 year total shareholder return of 23.14%, which suggests that momentum has...",
    "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "366cb14c-8d29-3a75-b321-72cb70abcf98",
      "content": {
        "id": "366cb14c-8d29-3a75-b321-72cb70abcf98",
        "contentType": "STORY",
        "title": "Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration",
        "description": "",
        "summary": "Amgen (AMGN) has just walked away from its licensing and collaboration agreement with Kyowa Kirin on rocatinlimab for atopic dermatitis, a portfolio reshuffle that shifts responsibility back to Kyowa Kirin and repositions Amgen’s near term pipeline focus. See our latest analysis for Amgen. Those portfolio moves sit alongside a share price that has climbed to US$344.68, with a 30 day share price return of 5.2% and a 1 year total shareholder return of 23.14%, which suggests that momentum has...",
        "pubDate": "2026-02-03T03:14:36Z",
        "displayTime": "2026-02-03T03:14:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "KYKOF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:24:06+00:00",
    "headline": "Jim Cramer on Amgen: “The Biotech Really Impressed Me With a Very Strong Pipeline”",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With Amgen, I don’t know if you remember, at the JPMorgan Healthcare Conference, I heard a lot of good things. The biotech really […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9e113368-7116-3838-a81d-867e64833c7c",
      "content": {
        "id": "9e113368-7116-3838-a81d-867e64833c7c",
        "contentType": "STORY",
        "title": "Jim Cramer on Amgen: “The Biotech Really Impressed Me With a Very Strong Pipeline”",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With Amgen, I don’t know if you remember, at the JPMorgan Healthcare Conference, I heard a lot of good things. The biotech really […]",
        "pubDate": "2026-02-03T12:24:06Z",
        "displayTime": "2026-02-03T12:24:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e",
          "originalWidth": 6144,
          "originalHeight": 3456,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yUwpYgqiuVEAjPqpC4y7Ww--~B/aD0zNDU2O3c9NjE0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e.cf.webp",
              "width": 6144,
              "height": 3456,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q.HNxvelm8rTEuW9n.Ys6Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:16:17+00:00",
    "headline": "Stocks Mostly Rise Pre-Bell as Investors Await Latest Round of Corporate Earnings",
    "summary": "US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate",
    "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "36c8c3ff-12fb-31be-8c10-4a8d88132e3c",
      "content": {
        "id": "36c8c3ff-12fb-31be-8c10-4a8d88132e3c",
        "contentType": "STORY",
        "title": "Stocks Mostly Rise Pre-Bell as Investors Await Latest Round of Corporate Earnings",
        "description": "",
        "summary": "US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate",
        "pubDate": "2026-02-03T12:16:17Z",
        "displayTime": "2026-02-03T12:16:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wall street stock market flag new york trading equity - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QVMgErJdOR7IkzCjRHm3pQ--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dimQxOClk1isv1IKNf9JtA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TER"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "NXPI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ITW"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "EA"
            },
            {
              "symbol": "TDG"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "ADM"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "EMR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]